All data are based on the daily closing price as of July 12, 2024
c

CHA Biotech

085660.KQ
11.87 USD
0.42
+3.67%

Overview

Last close
11.87 usd
Market cap
668.37M usd
52 week high
16.85 usd
52 week low
9.31 usd
Target price
15.58 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
1.0467
Price/Book Value
3.5488
Enterprise Value
1.15B usd
EV/Revenue
1.2855
EV/EBITDA
17.4967

Key financials

Revenue TTM
691.52M usd
Gross Profit TTM
135.82M usd
EBITDA TTM
3.02M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
1.31B usd
Net debt
N/A usd

About

Chabiotech Co.,Ltd., a bio company, develops cell and gene therapy related to stem and immune cells in South Korea and internationally. The company provides an umbilical cord blood consignment storage for the treatment of incurable diseases; regenerative medicines, immune cell and stem cell storage services, anti-aging, and solutions for incurable diseases; medical wellness programs, comprising fitness, spa, and scupplements; and customized development, production, clinical, and commercialization services to customers with research and development, and clinical experience. It offers optimized IT system construction and operation; consulting services for development, operation, and expansion of Chaum model; and solutions for maternal-centered genome testing and personalized healthcare. In addition, the company develops immune cells, such as CBT101 for recurrent glioblastoma and solid cancer, and CBT111 and CAR-NK for solid cancer; and stem cells, including CordSTEM-DD for chronic back pain, CordSTEM-POI for premature ovarian failure, CordSTEM-ST for stroke, CBT-NPC for Parkinson's disease, and hESC-RPE for macular degeneration and Stargardt's disease. Further, it offers IVF (fertility) services; cosmetics and cosmetic raw materials; medical devices and supplies; bioinsurance storage; research services; and other services. The company was founded in 2002 and is headquartered in Seoul, South Korea.
  • Symbol
    085660.KQ
  • Exchange
    KQ
  • Isin
    KR7085660009
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
    Hoon Oh Sang
  • Headquarter
    Seoul
  • Web site
    https://www.chabio.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top